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Abstract
Introduction: Preterm infants and young children with bronchopulmonary dysplasia
(BPD) are at increased risk for acute care utilization and chronic respiratory
symptoms during early life. Identifying risk factors for respiratory morbidities in the
outpatient setting could decrease the burden of care. We hypothesized that public
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insurance coverage was associated with higher acute care usage and respiratory
symptoms in preterm infants and children with BPD after initial neonatal intensive
care unit (NICU) discharge.
Methods: Subjects were recruited from BPD clinics at 10 tertiary care centers in the
United States between 2018 and 2021. Demographics and clinical characteristics
were obtained through chart review. Surveys for clinical outcomes were
administered to caregivers.
Results: Of the 470 subjects included in this study, 249 (53.0%) received employer‐
based insurance coverage and 221 (47.0%) received Medicaid as sole coverage at
least once between 0 and 3 years of age. The Medicaid group was twice as likely to
have sick visits (adjusted odd ratio [OR]: 2.06; p = 0.009) and emergency department
visits (aOR: 2.09; p = 0.028), and three times more likely to be admitted for
respiratory reasons (aOR: 3.04; p = 0.001) than those in the employer‐based group.
Additionally, those in the Medicaid group were more likely to have nighttime
respiratory symptoms (aOR: 2.62; p = 0.004).
Conclusions: Children with BPD who received Medicaid coverage were more likely
to utilize acute care and have nighttime respiratory symptoms during the first 3
years of life. More comprehensive studies are needed to determine whether the use
of Medicaid represents a barrier to accessing care, lower socioeconomic status, and/
or a proxy for detrimental environmental exposures.
KEYWORDS

bronchopulmonary dysplasia, insurance, Medicaid, rehospitalizations, respiratory morbidities,
socioeconomic
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| INTRODUCTION

outcomes in BPD, though the interplay with environmental and other
factors is complex.13 One of the socioeconomic factors that can affect

Bronchopulmonary dysplasia (BPD) is the most common respiratory

disease outcomes is health insurance coverage, which can reflect issues

complication of preterm birth, impacting nearly 50,000 infants per year,

related to access to care or may serve as a proxy for additional social

and contributing to chronic respiratory disease.1 Despite advances in

and environmental exposures influencing health status.

neonatal care, the incidence of BPD has remained constant.2 Infants and

Infants and young children with BPD may have significant health

young children with BPD are subject to a significant burden of disease,

care expenditures both during and after the initial NICU hospitaliza-

including prolonged initial neonatal intensive care unit (NICU) hospital-

tions.14 Costs are typically covered by third party payers in the

izations, frequent outpatient visits to general and subspecialty providers,

United State, and a substantial portion of preterm infants (45%) have

and an increased risk for readmission, particularly for respiratory

public insurance as their primary means of coverage.15 Very preterm

3

exacerbations.

Home treatment regimens may include respiratory

infants insured through Medicaid incur higher costs than those

medications, supplemental oxygen, and modes of respiratory support

covered by commercial insurance due to higher rates of morbidity

including noninvasive or invasive ventilation. Emerging data suggest that

and readmission after the birth hospitalization.16

4

early life events can affect long‐term lung function. For example, a

Prior studies examining whether insurance status is associated

history of radiologically diagnosed pneumonia during early childhood

with poor respiratory outcomes include two single center studies

can result in lower lung function in young adulthood.5 It is likely that

from Brown University in which Medicaid coverage was associated

6–8

thus

with an approximately twofold increased risk for readmission within

there is an impetus to identify factors that may impact disease severity

90 days of NICU discharge.17,18 However, it should be noted that

BPD may adversely affect long‐term lung function trajectories,

9

in early childhood when long‐term trajectories are most malleable.

another single center study reported that lower rates of readmission

Environmental contributions play an important role in long‐term

were associated with public insurance within the first 3 years of

pulmonary outcomes for preterm children, including second‐hand

life.19 In terms of multicenter studies, a study of 3574 infants with

10

11

and proximity to

BPD based on Pediatric Hospital Information System data reported

traffic pollution.12 Socioeconomic factors may also affect health

that private insurance was associated with 30% lower risk of

tobacco smoke exposure,

daycare attendance,
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readmissions within the first year of life,20 and investigators from the

US military and their dependents). Although Tricare coverage is

Prematurity and Respiratory Outcomes Program (PROP) reported

funded through the US federal government, it was treated as

that public insurance was associated increased respiratory morbidity,

employer‐based coverage based on a recent study of young children

a composite measure which included readmissions.21

with cystic fibrosis with Tricare coverage having respiratory

In this study we hypothesized that public insurance (Medicaid)

outcomes more akin to those with private insurance as opposed to

coverage would associate with readmissions, other acute care

other forms of public insurance coverage, including Medicaid.24

utilization (e.g., emergency department visits), and prolonged chronic

Subjects were classified into one of two groups based on all available

respiratory symptoms in childhood. We also sought to estimate risk

data: (1) always having employer‐based insurance or (2) any period of

of these adverse outcomes for different age groups within the first 3

time having public insurance (Medicaid) as sole coverage. Individuals

years of life to better understand the potential influences of

with employer‐based insurance and back‐up public insurance were

socioeconomic status on respiratory outcomes in BPD. To achieve

included in the employer‐based group. Pulmonary hypertension was

these goals, we utilized a multicenter outpatient registry of infants

defined as its presence on either echocardiography or cardiac

and children with BPD.

catheterization after 36 weeks corrected gestational age.25 Home
respiratory support was defined as any use of supplemental oxygen,
tracheostomy, or invasive/noninvasive positive pressure ventilation

2

| M E T H O D O L O GY

within the home setting. Pulmonary vasodilator medications included
any documented outpatient use of phosphodiesterase‐5 inhibitors,

2.1

| Study population

endothelin receptor antagonists, or prostanoids. Feeding tubes
included nasogastric, gastrostomy, gastrojejunostomy, and jejunost-

Participants were drawn from the BPD Collaborative Outpatient

omy tubes.

Registry on the basis of a diagnosis by the 2001 NHLBI workshop
definition, at least one clinical visit before 3 years of age, and
documentation of insurance coverage before 3 years of age.22,23 Ten

2.3 |

Data analysis

tertiary care centers recruited subjects through outpatient BPD
clinics and contributed data to the registry, including Arkansas

Demographic and inpatient characteristics (before 3 years of age;

Children's Hospital, Lucille Packard Children's Hospital Stanford,

sorted by insurance status) were compared by t‐tests and χ2 tests

Johns Hopkins Children's Center, Boston Children's Hospital,

(Table 1) as were outpatient characteristics at the time of recruitment

University of Massachusetts Memorial Children's Medical Center,

(Table 2). To test for associations between insurance status and acute

Children's Mercy Hospital Kansas City, Nationwide Children's

care use/chronic respiratory symptoms, odds ratios were generated

Hospital, Children's Hospital of Philadelphia, Monroe Carell Jr.

through logistic regression mixed models with clinic visits nested

Children's Hospital at Vanderbilt, and Intermountain Primary Chil-

within subjects nested within BPD centers to account for longitudinal

dren's Hospital at the University of Utah. Participating centers

data obtained at follow‐up clinic visits and to account for any center‐

obtained local review board approval and data use agreements were

specific variation (Table 3). All multivariate regressions were adjusted

completed between institutions for compiling anonymized data.

for age at the time of each clinic visit, race/ethnicity, birth weight,

Caregivers gave informed consent in accordance with local review

smokers in the home, and receipt of human milk at the time of the

board policies.

visit. STATA IC 15.0 (StataCorp) was used for all analyses. p values
less than 0.05 were considered significant.

2.2

| Data collection
3 |

RESULTS

Data collection instruments were generated by the BPD Collaborative as previously described.23 At the time of recruitment (September

3.1 |

Demographics and inpatient characteristics

2018 to July 2021), participant demographics, birth history, and
NICU history were collected via questionnaire and chart review. At

Of the 470 subjects who met inclusion criteria in the BPD

the time of recruitment and subsequent encounters in clinic, data on

Collaborative Outpatient Registry, 249 (53.0%) were reported to

secondhand smoke exposure, clinical characteristics, acute care use

always be on employer‐based insurance coverage and 221 (47.0%)

for respiratory reasons (since NICU discharge or the last clinic visit),

were reported to have been covered by Medicaid as sole coverage

and respiratory symptoms (reported in the past 4 weeks) were

for at least one clinical outpatient encounter between 0 and 3 years

collected via questionnaire and chart review. The term “sick visits”

of age (Table 1). Of the 221 subjects reported to have been covered

refers to urgent ambulatory care visits for respiratory reasons; data

by Medicaid for at least one encounter, 211 were reported to never

were not collected about routine visits to respiratory clinics.

have had employer‐based insurance, while the remaining 10 had

Employer‐based insurance was defined as having any private health

periods on employer‐based insurance. The percentage of subjects on

insurance or Tricare (healthcare coverage for members of the

Medicaid coverage ranged from 11.6% to 73.6% by center

1738
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Demographics and inpatient characteristics.
Entire study
population(n = 470)

Always employer
insurance(n = 249)

Any period with
Medicaid as sole
coverage(n = 221)

Sex (% female)

43.7
(n = 467)

42.7
(n = 248)

44.8
(n = 219)

0.66

Race (% non‐white)

43.4
(n = 463)

32.9(n = 246)

55.3
(n = 217)

<0.001

Ethnicity (% Hispanic)

10.9
(n = 466)

4.9
(n = 246)

17.7
(n = 220)

<0.001

Gestational age (weeks)

26.7 ± 2.4
[22.3−33.9]

26.9 ± 2.3
[22.3−33.7]

26.6 ± 2.6
[22.3−33.9]

0.19

Birth weight (g)

907 ± 357
[370−2890]
(n = 469)

940 ± 370
[370−2890]
(n = 248)

871 ± 340
[370−2100]

0.038

Length of initial admission (months)

4.8 ± 2.8
[1.0−18.0]
(n = 459)

4.6 ± 2.5
[1.0−14.5]
(n = 244)

5.1 ± 3.1
[1.0−18.0]
(n = 215)

0.06

8.9
21.5
69.6

11.2
19.7
69.1

6.3
23.5
70.1

0.14

Cerebrospinal fluid shunt (% yes)

6.7
(n = 463)

5.3
(n = 247)

8.3
(n = 216)

0.19

Pulmonary hypertension after 36 weeks
(% yes)

21.5
(n = 465)

19.8
(n = 248)

23.5
(n = 217)

0.33

Cyanotic heart disease (% yes)

1.1
(n = 469)

1.2

0.9
(n = 220)

0.76

Congenital anomaly or syndrome (% yes)

8.7
(n = 458)

9.5
(n = 243)

7.9
(n = 215)

0.61

Mean ± SD[range]

p Value

BPD severity (%)
Mild
Moderate
Severe

Note: Bold values are significant at p < 0.05.
Abbreviations: BPD, bronchopulmonary dysplasia; SD, standard deviation.

(p < 0.001). While there were no differences by sex between the

3.2 |

Outpatient characteristics

health insurance groups (p = 0.66), those in the Medicaid group were
more likely to be non‐white (55.3% vs. 32.9%; p < 0.001) and/or

The mean age of recruitment into the registry was 0.9 ± 0.7 years of

Hispanic (17.7% vs. 4.9%; p < 0.001) than those in the employer‐

age, which did not differ by health insurance group (p = 0.19)

based insurance group. The mean gestational age for the study

(Table 2). Similar to the demographic and inpatient characteristics,

population was 26.7 ± 2.4 weeks and did not differ by insurance

the two groups did not differ by most outpatient characteristics at

group (p = 0.19). However, those in the Medicaid group had a lower

the time of recruitment. There were no differences in the use of the

mean birth weight (871 ± 340 g) than those in the employer insurance

following home therapies by insurance status: nasal cannula oxygen,

group (940 ± 370 g; p = 0.038). Overall, 8.9% of the study population

tracheostomy, home ventilation, use of inhaled steroids, medications

was diagnosed with mild BPD, 21.5% with moderate BPD, and 69.6%

for pulmonary hypertension, or feeding tubes. There were some

with severe BPD, and the frequencies were similar between health

differences in important home environment factors. Specifically,

insurance groups (p = 0.14). There was a trend toward longer initial

those in the Medicaid group were 7.3 times more likely to be exposed

NICU admissions (0.5 months; p = 0.06) within the Medicaid group.

to secondhand smoke (23.5% vs. 3.2%; p < 0.001) and 61% less likely

There were no differences between the groups in terms of the

to be receiving human milk (13.1% vs. 33.7%; p < 0.001) than those in

presence of cerebrospinal fluid shunts, pulmonary hypertension after

the employer‐based insurance group. There were no differences in

36 weeks postmenstrual age, cyanotic heart disease, or congenital

daycare attendance (p = 0.46) or number of children living in the

anomalies or syndromes.

home (p = 0.09).

COLLACO
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Outpatient clinical characteristics at time of recruitment.
Entire study
population(n = 470)

Always employer
insurance(n = 249)

Any period with
Medicaidas sole
coverage(n = 221)

Age at recruitment (years)

0.9 ± 0.7
[0.1−3.0]

0.9 ± 0.7
[0.2−3.0]

0.8 ± 0.6
[0.1−3.0]

0.19

Children in the home (#)

2.0 ± 1.2
(1−7)
(n = 457)

1.9 ± 1.2
(1−6)
(n = 243)

2.1 ± 1.3
(1−7)
(n = 214)

0.09

Daycare (% yes)

19.9
(n = 462)

18.6
(n = 247)

21.4
(n = 215)

0.46

Secondhand smoke (% yes)

12.8

3.2

23.5

<0.001

Nasal cannula oxygen (% yes)

42.3

41.0

43.9

0.52

Tracheostomy (% yes)

13.0

12.1

14.0

0.52

Home ventilator (% yes)

10.0

11.3

8.8

0.37

Inhaled steroids (% yes)

50.4

48.2

52.9

0.30

Pulmonary hypertension
medications (% yes)

8.5

7.6

9.5

0.47

Feeding tube (% yes)

37.1
(n = 469)

34.1

40.5
(n = 220)

0.16

Any human milk (% yes)

24.0

33.7

13.1

Mean ± SD [range]

p Value

<0.001

Note: Bold values are significant at p < 0.05.
Abbreviation: SD, standard deviation.

3.3

| Clinical outcomes

and add to them to observing associations between insurance status
and other modalities of acute care, specifically a twofold increased

We examined acute care use, respiratory symptoms, and medication

risk for both sick visits and emergency department visits. We found

use by insurance status using mixed logistic regression models

that nighttime respiratory symptoms were associated with Medicaid

(Table 3). After adjusting for factors that differed between the two

coverage. Our data do not indicate whether poorer outcomes

health insurance groups, we found that those in the Medicaid group

associated with Medicaid coverage are a function of decreased

were twice as likely to have sick visits (urgent ambulatory care visits;

access to care or whether insurance status is a proxy for reduced

aOR: 2.06; p = 0.009) and emergency department visits (aOR: 2.09;

socioeconomic status or other environmental factors.

p = 0.028) and three times more likely to be admitted for respiratory

We found that subjects with Medicaid coverage accessed the

symptoms (aOR: 3.04; p = 0.001) than those in the employer‐based

primary care provider for acute sick visits and visited the emergency

insurance group. There were no differences in antibiotic (p = 0.79) or

department at twice the rate of those with employer‐based coverage.

systemic steroid use (p = 0.14). Additionally, those in the Medicaid

These increased rates of acute care use could stem from difficulties in

group were more likely to have nighttime respiratory symptoms

accessing preventative care (e.g., local providers may not take Medicaid,

(aOR: 2.62; p = 0.004) than those in the employer‐based insurance

travel considerations, absence of caregiver job flexibility). A 2019 single

group. There were no differences in any of the other chronic

center study found that only 53% of 107 preterm children received care

respiratory symptoms or medication use by health insurance group.

through a medical home (defined as having a personal doctor/nurse, a
usual place for care, effective care coordination, family‐centered care, and
getting referrals when needed) with lower rates were observed among

4

| DISC US SION

those with lower socioeconomic status.26 An interdisciplinary medical
home for preterm infants with severe BPD has been recommended by

In this multicenter registry‐based study of infants and young children

experts.3 Additionally, those with public insurance may have been sicker

with BPD, we found that Medicaid coverage was associated with a

as a result of delays in accessing care. This is supported by our

threefold risk for hospital admission within the first 3 years of life

observation that public insurance was associated with a threefold risk for

after adjusting for potential confounders. Our findings extend results

hospital readmission, as compared to a twofold risk for sick visits or

from previous studies where increased rates of readmission were

emergency department visits as compared to those with employer‐based

seen within the first year of life17,18,20,21 to the first 3 years of life,

insurance.

1740
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Clinical outcomes with lack of employer‐based insurance.
Unadjusted odds ratio
with no employer
insurance

OR ± SEa [95% CI]
Acute care

Chronic symptoms and
medication use

p Value

Adjusted odds ratio
with no employer
insurance

p Value

Sick visits (urgent ambulatory
care visits)

1.87 ± 0.48
[1.13−3.09]
(n = 463 with 965 visits)

0.015

2.06 ± 0.57
[1.20−3.53]
(n = 458 with 948 visits)

0.009

Emergency department visits

2.36 ± 0.73
[1.29−4.31]
(n = 461 with 964 visits)

0.006

2.09 ± 0.70
[1.08−4.02]
(n = 456 with 947 visits)

0.028

Hospital readmissions

2.98 ± 0.92
[1.62−5.47]
(n = 462 with 964 visits)

<0.001

3.04 ± 1.03
[1.56−5.91]
(n = 457 with 947 visits)

0.001

Antibiotics

1.02 ± 0.29
[0.58−1.78]
(n = 460 with 960 visits)

0.94

1.09 ± 0.34
[0.59−2.02]
(n = 455 with 943 visits)

0.79

Systemic steroids

2.04 ± 0.75
(1.00−4.18)
(n = 455 with 954 visits)

0.05

1.79 ± 0.70
[0.83−3.86]
(n = 450 with 937 visits)

0.14

Trouble breathing

1.53 ± 0.35
[0.98−2.40]
(n = 465 with 958 visits)

0.06

1.56 ± 0.40
[0.94−2.58]
(n = 459 with 940 visits)

0.08

Nighttime respiratory
symptoms

2.36 ± 0.71
[1.30−4.27]
(n = 466 with 959 visits)

0.005

2.62 ± 0.87
[1.37−5.02]
(n = 460 with 941 visits)

0.004

Activity limitations

1.48 ± 0.47
[0.79−2.75]
(n = 461 with 952 visits)

0.22

1.62 ± 0.57
[0.82−3.23]
(n = 455 with 934 visits)

0.17

Rescue medication use

1.35 ± 0.39
[0.77−2.37]
(n = 463 with 954 visits)

0.30

1.05 ± 0.34
[0.56−1.97]
(n = 457 with 936 visits)

0.89

Note: Bold values are significant at p < 0.05.
Abbreviations: BPD, bronchopulmonary dysplasia; OR, odd ratio; SE, standard error.
a

Odds ratios were generated through multivariate nested mixed logistic regression models with clinic visits (before 3 years of age) nested within subjects
nested within BPD centers. Exposure (Medicaid coverage) and outcomes were coded as no = 0 and yes = 1. Adjusted regression models were adjusted for
age at the time of clinic visit, birthweight, race/ethnicity (coded as non‐Hispanic White = 1 and all others = 1), smokers in the home, and receipt of human
milk at the time of visit.

Conversely, insurance status may be solely a marker for other social

We also observed that birth weights were lower within the

or economic disparities, rather a true detriment to health. For example, a

Medicaid group as compared to the employer‐based insurance group

study in pediatric patients with cystic fibrosis demonstrated that

despite having similar gestational ages. The etiology for this is likely

differential use of health services or prescription of chronic therapy

multifactorial and may include decreased access to prenatal care,

was not explained by insurance status.27 We observed in our population

reduced maternal nutrition, and increased maternal exposure to

that Medicaid status was associated with an increased likelihood of a

tobacco smoke. Although there was a trend toward longer admissions

smoker residing within the home and a decreased likelihood of receiving

within the Medicaid group (p = 0.06), this was not significant in a

human milk, both of which have been associated with poor respiratory

regression model after adjusting for birth weight (p = 0.24).

outcomes in preterm infants.10,28 In a larger context, these potential
exposures that were correlated in our study (Medicaid coverage,
secondhand smoke, and decreased human milk intake) may be general

4.1 |

Limitations

markers for reduced socioeconomic status, and in turn other exposures
such as increased exposure to pollution from traffic, industrial sites,

One of the limitations of our study is that insurance coverage is not

crowded living situations with increased sick contacts, etc. Some of these

static. Recent data from children and young adults with cystic fibrosis

detrimental exposures may be responsible for the increased nighttime

suggests that a large fraction of the population may transition

symptoms seen within the Medicaid group.

between employer‐based insurance and Medicaid coverage over a
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multiyear period with effects on respiratory outcomes.29,30 The

A UT H O R C O N T R I B U TI O NS

resolution of our data does not allow for accurate assessment of

Joseph M. Collaco: Conceptualization (equal); Methodology (equal);

insurance as a time‐varying exposure. Additionally, while our centers

Formal Analysis (equal); data curation (equal); resources (equal);

are geographically diverse, eligibility criteria for Medicaid varies by

writing—original (equal). Michael C. Tracy: Conceptualization (equal);

state and we may have state or regional biases for Medicaid coverage

resources (equal); writing—review and editing (equal). Jessica L. Rice:

in our study population. Our study population is recruited from

Conceptualization (equal); resources (equal); writing—review and

patients who access specialized BPD care at academic medical

editing (equal). Catherine A. Sheils: Conceptualization (equal);

center, and is also enriched for more severe BPD compared to the

funding acquisition (equal); resources (equal); writing—review and

general preterm population,31 which may limit the generalizability of

editing (equal). Lawrence M. Rhein: Conceptualization (equal);

our findings. Also, there may be disparities associated with both the

resources (equal); writing—review and editing (equal). Leif D. Nelin:

exposure and outcomes in our study as we observed that Medicaid

Conceptualization (equal); data curation (equal); funding acquisition

coverage was associated with both non‐white race and Hispanic

(equal); project administration (equal); resources (equal); writing—

ethnicity; our adjustments in the regression models may not

review and editing (equal). Paul E. Moore: Conceptualization (equal);

completely adjust for confounding secondary to race and ethnicity

resources (equal); writing—review and editing (equal). Winston M.

due to race being coded as a dichotomous variable. Thus, while we

Manimtim: Conceptualization (equal); resources (equal); writing—

did not collect data on racism or discrimination, it may be possible

Review and editing (equal). Jonathan C. Levin: Conceptualization

that some part of the association we observed between insurance

(equal); resources (equal); writing—review and editing (equal). Khanh

status and respiratory outcomes could be secondary to racism, based

Lai: Conceptualization (equal); resources (equal); writing—review and

on other studies of maternal and preterm child health.32–34 We also

editing (equal). Lystra P. Hayden: Conceptualization (equal); funding

did not assess caregiver education level, which may impact the ability

acquisition (equal); resources (equal); writing—review and editing

to recognize and act on respiratory symptoms early to decrease the

(equal). Julie L. Fierro: Conceptualization (equal); resources (equal);

likelihood of acute care use. Lastly, we did not assess specific

writing—review and editing (equal). Eric D. Austin: Conceptualization

financial considerations for accessing care such as copays and

(equal); funding acquisition (equal); resources (equal); writing—review

deductibles or household income, which may incentivize or disin-

and editing (equal). Stamatia Alexiou: Conceptualization (equal);

centivize particular modalities of care.

resources (equal); writing—review and editing (equal). Amit Agarwal:
Conceptualization (equal); resources (equal); writing—review and
editing (equal). Natalie Villafranco: Conceptualization (equal);

5

| C ONC LUS I ON S

writing—review and editing (equal). Roopa Siddaiah: Conceptualization (equal); writing—review and editing (equal). Antonia P. Popova:

In summary, we observed increased acute care utilization among those

Conceptualization (equal); writing—review and editing (equal). Ioana

covered by Medicaid in a multicenter population of infants and young

A. Cristea: Conceptualization (equal); writing—review and editing

children with primarily severe BPD. This may have short‐term ramifica-

(equal). Christopher D. Baker: Conceptualization (equal); writing—

tions for health care utilization and costs for state and federal funding

review and editing (equal). Manvi Bansal: Conceptualization (equal);

agencies as well as quality of life for families. Increased acute care use for

writing—review and editing (equal). Sharon A. McGrath‐Morrow:

preterm infants and children with BPD is associated with lower quality of

Conceptualization (equal); Methodology (equal); data curation;

life for caregivers.35 More problematically, the associations we observed

resources (equal); writing—review and editing (equal); supervision

may be part of a worse longer‐term trajectory among preterm individuals,

(equal).

receiving Medicaid coverage. A 2018 study of 882 preterm infants born
at less than 28 weeks gestation found that maternal Medicaid coverage

ACKNOWLEDGME NT S

among preterm infants was associated with a 1.8‐fold risk of later

We wish to thank the families who participated in this study. This

development of asthma at 10 years of age36; asthma being more

study was supported by the National Institutes of Health/National

common among preterm individuals in general.1 Further work is also

Heart, Lung, and Blood Institute (Bethesda, MD, USA) (S. A. M.: R01

needed to determine whether insurance coverage directly impacts

HL114800; L. P. H.: K23 HL 136851; A. P. P.: R01 HL140572; E. D.

outcomes (i.e., is insurance coverage associated with access to medica-

A.: R01 HL134802) and the Children's Hospital of Philadelphia

tions, therapies, and care?). If insurance is only a marker of other

(J. M. C.).

disparities or inequities, including access to a medical home, more
comprehensive studies of socioeconomic and environmental factors

CONFLIC TS OF I NTERES T

affecting infants with postprematurity respiratory disease are needed to

The authors declare no conflicts of interest.

identify risk factors and the complex interplay between social, economic,
and medical factors. Although clinical interventions (e.g., standardization

DATA AVAILABILITY STATEMENT

of care based on evidence‐based guidelines)37,38 may decrease some of

The data that support the findings of this study are available on

the disparate outcomes observed with insurance status, changes in social

request from the corresponding author. The data are not publicly

and economic policies are also needed.39

available due to privacy or ethical restrictions.

1742

|

COLLACO

ORCID

16.

Joseph M. Collaco

http://orcid.org/0000-0002-2581-4372

Michael C. Tracy
Jessica L. Rice

http://orcid.org/0000-0003-0474-1669
http://orcid.org/0000-0002-3346-3963

Lawrence M. Rhein
Paul E. Moore

http://orcid.org/0000-0001-5123-207X

Julie L. Fierro

http://orcid.org/0000-0002-9454-5954

Eric D. Austin

http://orcid.org/0000-0002-1709-9022

Christopher D. Baker
Manvi Bansal

17.

http://orcid.org/0000-0001-5703-8833

http://orcid.org/0000-0002-1171-563X

18.

19.

http://orcid.org/0000-0002-3030-7754

Sharon A. McGrath‐Morrow

http://orcid.org/0000-0002-

1576-5394

20.

REFERENCES
1.

2.

3.

4.
5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

15.

Collaco JM, McGrath‐Morrow SA. Respiratory phenotypes for
preterm infants, children, and adults: bronchopulmonary dysplasia
and more. Ann Am Thorac Soc. 2018;15(5):530‐538.
Smith VC, Zupancic JA, McCormick MC, et al. Trends in severe
bronchopulmonary dysplasia rates between 1994 and 2002.
J Pediatr. 2005;146(4):469‐473.
Abman SH, Collaco JM, Shepherd EG, et al. Interdisciplinary care of
children with severe bronchopulmonary dysplasia. J Pediatr. 2017;
181:12‐28 e11.
Martinez FD. Early‐life origins of chronic obstructive pulmonary
disease. N Engl J Med. 2016;375(9):871‐878.
Chan JY, Stern DA, Guerra S, Wright AL, Morgan WJ, Martinez FD.
Pneumonia in childhood and impaired lung function in adults: a
longitudinal study. Pediatrics. 2015;135(4):607‐616.
Hirata K, Nishihara M, Kimura T, et al. Longitudinal impairment of
lung function in school‐age children with extremely low birth
weights. Pediatr Pulmonol. 2017;52(6):779‐786.
Doyle LW, Irving L, Haikerwal A, Lee K, Ranganathan S, Cheong J.
Airway obstruction in young adults born extremely preterm or extremely
low birth weight in the postsurfactant era. Thorax. 2019;74(12):
1147‐1153.
Levin JC, Sheils CA, Gaffin JM, Hersh CP, Rhein LM, Hayden LP.
Lung function trajectories in children with post‐prematurity respiratory disease: identifying risk factors for abnormal growth. Respir Res.
2021;22(1):143.
Collaco JM, McGrath‐Morrow SA. Bronchopulmonary dysplasia as a
determinant of respiratory outcomes in adult life. Pediatr Pulmonol.
2021;56:974‐981.
Collaco JM, Aherrera AD, Breysse PN, Winickoff JP, Klein JD,
McGrath‐Morrow SA. Hair nicotine levels in children with bronchopulmonary dysplasia. Pediatrics. 2015;135(3):e678‐e686.
McGrath‐Morrow SA, Lee G, Stewart BH, et al. Day care increases
the risk of respiratory morbidity in chronic lung disease of
prematurity. Pediatrics. 2010;126(4):632‐637.
Collaco JM, Morrow M, Rice JL, McGrath‐Morrow SA. Impact of
road proximity on infants and children with bronchopulmonary
dysplasia. Pediatr Pulmonol. 2020;55(2):369‐375.
Collaco JM, Aoyama BC, Rice JL, McGrath‐Morrow SA. Influences of
environmental exposures on preterm lung disease. Expert Rev Respir
Med. 2021;15(10):1271‐1279.
Mowitz ME, Mangili A, Han L, et al. Prevalence of chronic
respiratory morbidity, length of stay, inpatient readmissions, and
costs among extremely preterm infants with bronchopulmonary
dysplasia. Expert Rev Pharmacoecon Outcomes Res. 2021:1117‐1125
Bockli K, Andrews B, Pellerite M, Meadow W. Trends and challenges
in United States neonatal intensive care units follow‐up clinics.
J Perinatol. 2014;34(1):71‐74.

21.

22.
23.

24.

25.

26.

27.

28.

29.

30.

31.

32.

33.

34.

ET AL.

Barradas DT, Wasserman MP, Daniel‐Robinson L, et al.
Hospital utilization and costs among preterm infants by payer:
nationwide inpatient sample, 2009. Matern Child Health J. 2016;
20(4):808‐818.
Abdulla L, McGowan EC, Tucker RJ, Vohr BR. Disparities in preterm
infant emergency room utilization and rehospitalization by maternal
immigrant status. J Pediatr. 2020;220:27‐33.
Vohr B, McGowan E, Keszler L, et al. Impact of a transition home
program on rehospitalization rates of preterm infants. J Pediatr.
2017;181:86‐92.e81.
Collaco JM, Choi SJ, Riekert KA, Eakin MN, McGrath‐Morrow SA,
Okelo SO. Socio‐economic factors and outcomes in chronic lung
disease of prematurity. Pediatr Pulmonol. 2011;46(7):709‐716.
Lagatta J, Murthy K, Zaniletti I, et al. Home oxygen use and 1‐year
readmission among infants born preterm with bronchopulmonary
dysplasia discharged from children's hospital neonatal intensive care
units. J Pediatr. 2020;220:40‐48.e45.
Keller RL, Feng R, DeMauro SB, et al. Bronchopulmonary dysplasia
and perinatal characteristics predict 1‐year respiratory outcomes in
newborns born at extremely low gestational age: a prospective
cohort study. J Pediatr. 2017;187:89‐97.e83.
Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit
Care Med. 2001;163(7):1723‐1729.
Collaco JM, Agarwal A, Austin ED, et al. Characteristics of infants or
children
presenting
to
outpatient
bronchopulmonary
dysplasia clinics in the United States. Pediatr Pulmonol. 2021;56:
1617‐1625.
Collaco JM, Vanscoy LL, Psoter KJ, Riekert KA, Dickinson KM.
Clinical outcomes in cystic fibrosis at 6 years of age with tricare
insurance coverage. J Cyst Fibros. 2022; S1569‐1993(22)00036‐4.
doi:10.1016/j.jcf.2022.02.004
Abman SH, Hansmann G, Archer SL, et al. Pediatric Pulmonary
Hypertension: guidelines from the American Heart Association
and American Thoracic Society. Circulation. 2015;132(21):
2037‐2099.
Boone KM, Nelin MA, Chisolm DJ, Keim SA. Gaps and factors
related to receipt of care within a medical home for toddlers born
preterm. J Pediatr. 2019;207:161‐168.e161.
Schechter MS, McColley SA, Silva S, Haselkorn T, Konstan MW,
Wagener JS. Association of socioeconomic status with the use of
chronic therapies and healthcare utilization in children with cystic
fibrosis. J Pediatr. 2009;155(5):634‐639.
Kim LY, McGrath‐Morrow SA, Collaco JM. Impact of breast milk on
respiratory outcomes in infants with bronchopulmonary dysplasia.
Pediatr Pulmonol. 2019;54(3):313‐318.
Tumin D, Crowley EM, Li SS, Wooten W, Ren CL, Hayes D Jr. Patterns
of health insurance coverage and lung disease progression in adolescents
and young adults with cystic fibrosis. Ann Am Thorac Soc. 2021;18(2):
290‐299. doi:10.1513/AnnalsATS.201911‐839OC>
Dickinson KM, Psoter KJ, Riekert KA, Collaco JM. Association
between insurance variability and early lung function in children
with cystic fibrosis. J Cyst Fibros. 2021;21:104‐110.
Ehrenkranz RA, Walsh MC, Vohr BR, et al. Validation of the National
Institutes of Health consensus definition of bronchopulmonary
dysplasia. Pediatrics. 2005;116(6):1353‐1360.
Alhusen JL, Bower KM, Epstein E, Sharps P. Racial discrimination and
adverse birth outcomes: an integrative review. J Midwifery Womens
Health. 2016;61(6):707‐720.
Collins JW, Jr., David RJ, Handler A, Wall S, Andes S. Very low
birthweight in African American infants: the role of maternal exposure to
interpersonal racial discrimination. Am J Public Health. 2004;94(12):
2132‐2138.
Adegoke TM, Pinder LF, Ndiwane N, Parker SE, Vragovic O,
Yarrington CD. Inequities in adverse maternal and perinatal

COLLACO

35.

36.

37.

|

ET AL.

outcomes: the effect of maternal race and nativity. Matern Child
Health J. 2021;26:823‐833.
McGrath‐Morrow SA, Ryan T, Riekert K, Lefton‐Greif MA,
Eakin M, Collaco JM. The impact of bronchopulmonary dysplasia
on caregiver health related quality of life during the first 2 years
of life. Pediatr Pulmonol. 2013;48(6):579‐586.
Jackson WM, O'Shea TM, Allred EN, Laughon MM, Gower WA,
Leviton A. Risk factors for chronic lung disease and asthma differ
among children born extremely preterm. Pediatr Pulmonol. 2018;
53(11):1533‐1540.
Cristea AI, Ren CL, Amin R, et al. Outpatient respiratory management of infants, children, and adolescents with post‐prematurity
respiratory disease: an official american thoracic society clinical
practice guideline. Am J Respir Crit Care Med. 2021;204(12):
e115‐e133.

38.

39.

1743

Duijts L, vanMeel ER, Moschino L, et al. European respiratory society
guideline on long‐term management of children with bronchopulmonary dysplasia. Eur Respir J. 2020;55:1.
Oates GR, Schechter MS. Social inequities and cystic fibrosis
outcomes: we can do better. Ann Am Thorac Soc. 2021;18(2):
215‐217.

How to cite this article: Collaco JM, Tracy MC, Sheils CA,
et al. Insurance coverage and respiratory morbidities in
bronchopulmonary dysplasia. Pediatric Pulmonology. 2022;57:
1735‐1743. doi:10.1002/ppul.25933

